Tempest Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Tempest Therapeutics, Inc. (TPST) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $534.50 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $534.50M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $502.20M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $482.10M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $466.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $534.50M 10-K · filed 2026-03-30 |
| 2024-12-31 | $502.20M 10-K · filed 2026-03-30 |
| 2023-12-31 | $482.10M 10-K · filed 2025-03-27 |
| 2022-12-31 | $466.00M 10-K · filed 2024-03-19 |
| 2021-12-31 | $452.40M 10-K · filed 2023-03-22 |
| 2020-12-31 | $80.90M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |